| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
Net loss | |||||||||
-20,520 | -39,171 | -46,425 | - | - | - | - | - | - | - |
Net loss | |||||||||
- | - | - | 193,854 | -3,440 | -9,955 | -11,718 | -4,920 | -3,797 | -34,849 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Non-cash consideration for acquired in-process research and development | |||||||||
6,541 | - | - | - | - | - | - | - | - | - |
Impairment charges | |||||||||
1,000 | 24,940 | 35,919 | - | - | - | - | - | - | - |
Realization of cumulative translation adjustment | |||||||||
- | - | - | 0 | 229 | 0 | 0 | -1,227 | - | 0 |
Realization of cumulative translation adjustment | |||||||||
- | - | - | - | - | - | - | -1,227 | - | 0 |
Realization of cumulative translation adjustment | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Stock-based compensation | |||||||||
1,264 | 773 | 1,443 | 2,240 | 613 | 1,655 | 1,362 | 1,894 | 2,565 | 2,513 |
Depreciation | |||||||||
239 | 218 | 83 | 143 | 141 | 149 | 182 | 303 | 461 | - |
Amortization | |||||||||
147 | 83 | 55 | - | - | - | - | - | - | - |
Unrealized losses (gains) on foreign currency exchange | |||||||||
5 | -64 | - | - | - | - | - | - | - | - |
Debt discount accretion | |||||||||
- | 180 | - | - | - | - | - | - | - | - |
Debt discount accretion | |||||||||
- | - | 98 | - | - | - | - | - | - | - |
Amortization of premium and discount on short-term investments | |||||||||
- | - | - | -35 | 0 | 0 | - | - | - | - |
Non-cash interest expense | |||||||||
- | - | - | -15 | 45 | -83 | - | - | - | - |
Restructuring expense related to property and equipment | |||||||||
- | - | - | 0 | 36 | 0 | 0 | - | - | - |
Non-cash interest expense | |||||||||
- | - | - | - | - | - | 135 | 122 | 0 | 4,653 |
Impairment of assets held for sale | |||||||||
- | - | - | - | - | - | - | - | - | 4,635 |
Gain on the disposal of assets held for sale | |||||||||
- | - | - | - | - | - | - | - | 781 | 0 |
Gain from disposal of property and equipment | |||||||||
- | 3 | -9 | 0 | 7 | 5 | 3 | 66 | 0 | 0 |
Changes in fair value of warrant liability | |||||||||
-30 | 2,878 | - | - | - | - | - | - | - | - |
Changes in fair value of warrant liability, including loss on exchange | |||||||||
- | - | 97 | - | - | - | - | - | - | - |
Changes in fair value of embedded derivative | |||||||||
- | 184 | -7 | -957 | 299 | 508 | -444 | 591 | 7,144 | -5,457 |
Bad debt recovery | |||||||||
- | - | - | - | - | - | - | - | -40 | 2,935 |
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | |||||||||
-2,440 | -344 | 1,948 | -210 | 401 | -1,316 | -1,005 | -1,991 | -20 | -1,279 |
Prepaid expenses and other current assets | |||||||||
-133 | -499 | 349 | 283 | -5 | 5 | -282 | -367 | -1,481 | 650 |
Other long-term assets and deferred costs | |||||||||
- | - | - | -53 | 0 | 0 | - | - | - | - |
Accounts payable | |||||||||
-354 | 243 | -2,623 | 405 | 129 | -736 | -569 | 251 | -1,682 | 1,245 |
Accrued restructuring expenses | |||||||||
- | - | - | -397 | 481 | 0 | 0 | - | - | - |
Accrued expenses and other current liabilities | |||||||||
-626 | 17 | -364 | 789 | -54 | -2,089 | 773 | -418 | -391 | -8,513 |
Deferred revenue | |||||||||
22 | -19 | -19 | - | - | - | - | - | - | - |
Accrued income taxes payable | |||||||||
- | - | - | 3,157 | 0 | 0 | - | - | - | - |
Deferred revenue | |||||||||
- | - | - | 0 | 0 | -341 | -1,040 | 867 | 514 | 0 |
Deferred rent | |||||||||
- | -818 | -22 | - | - | - | - | - | - | - |
Lease obligation | |||||||||
175 | - | - | - | - | - | - | - | - | - |
Unbilled accounts receivable | |||||||||
- | - | - | -266 | 665 | -1,902 | -1,914 | 1,093 | -987 | -5,408 |
Tax refund receivable | |||||||||
-379 | -5,077 | 3,406 | - | - | - | - | - | - | - |
Depreciation expense | |||||||||
- | - | - | - | - | - | - | - | - | 1,020 |
Deferred tax benefit | |||||||||
-58 | -6,149 | -2,617 | 61 | 61 | 61 | 61 | 195 | 0 | 0 |
Purchases of available-for-sale investments | |||||||||
- | - | - | 66,847 | 0 | 0 | - | - | - | - |
Net cash used in operating activities | |||||||||
-9,601 | -9,388 | -20,214 | - | - | - | - | - | - | -14,864 |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
Purchases of short-term investments | |||||||||
28,257 | - | - | - | - | - | - | - | - | - |
Cash assumed in acquisition | |||||||||
- | - | 13,684 | - | - | - | - | - | - | - |
Net cash used in operating activities | |||||||||
- | - | - | 201,508 | -3,215 | -8,474 | -7,168 | -2,322 | -7,808 | - |
Purchase of property and equipment | |||||||||
1 | 975 | 112 | 30 | 86 | 92 | 84 | 0 | 71 | 374 |
Proceeds from the disposal of assets held for sale | |||||||||
- | - | - | - | - | - | - | - | 1,758 | 0 |
Proceeds from sale of property and equipment | |||||||||
- | 14 | 7 | 0 | 7 | 8 | 3 | 67 | 0 | 0 |
Cash paid for internally developed patents | |||||||||
27 | 40 | 53 | - | - | - | - | - | - | - |
Refund of cash held in escrow | |||||||||
- | - | 200 | - | - | - | - | - | - | - |
Proceeds from sales of short-term investments | |||||||||
- | - | - | - | - | - | - | - | - | 3,130 |
Net cash provided by (used in) investing activities | |||||||||
-28,286 | -1,001 | 13,725 | - | - | - | - | - | - | 2,756 |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
Net cash (used in) provided by investing activities | |||||||||
- | - | - | -66,877 | -78 | -84 | -81 | 67 | 1,687 | - |
Repayments of notes payable | |||||||||
292 | 1,549 | 212 | - | - | - | - | - | - | - |
Proceeds from issuance of convertible notes, net of issuance costs | |||||||||
- | - | 3,018 | - | - | - | - | - | - | - |
Redemption of preferred stock | |||||||||
- | 2,386 | - | - | - | - | - | - | - | - |
Cash paid in conjunction with warrant exchange | |||||||||
25 | 1,100 | - | - | - | - | - | - | - | - |
Proceeds from conditional economic incentive | |||||||||
150 | 100 | - | - | - | - | - | - | - | - |
Proceeds from issuance of common stock, net of issuance costs | |||||||||
- | 4,334 | - | 3,801 | 973 | 18,141 | 6,018 | 38 | 5,855 | - |
Proceeds from issuance of common units, net of issuance costs | |||||||||
12,668 | 33,068 | - | - | - | - | - | - | - | - |
Repayment of debt | |||||||||
- | - | - | 0 | -750 | -999 | -749 | 2,500 | 0 | - |
Proceeds from issuance of long-term debt | |||||||||
- | - | - | - | - | - | - | - | - | -11 |
Net repayment of revolving credit agreement | |||||||||
- | - | - | 0 | 0 | -1,091 | -238 | 1,330 | 0 | 0 |
Deferred financing costs | |||||||||
- | - | - | - | - | - | - | 216 | 0 | 0 |
Change in restricted cash requirements | |||||||||
- | - | - | - | - | - | - | 100 | 0 | -100 |
Proceeds from exercises of warrants | |||||||||
- | - | - | 0 | 0 | 683 | 0 | 0 | - | - |
Proceeds from exercise of warrants and stock options | |||||||||
30 | 22 | - | - | - | - | - | - | - | - |
Proceeds from exercise of stock options | |||||||||
- | - | 16 | - | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
12,532 | 32,489 | 15,841 | - | - | - | - | - | - | 21,460 |
Proceeds from issuance of common stock and warrants | |||||||||
- | - | - | - | - | - | - | - | - | 21,601 |
Other | |||||||||
- | - | - | -0 | 0 | 0 | - | -32 | -74 | -29 |
Net cash provided by financing activities | |||||||||
- | - | - | 3,800 | 223 | 16,733 | 5,030 | 3,720 | 5,781 | - |
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | |||||||||
- | -50 | 74 | - | - | - | - | - | - | - |
Net increase in cash and cash equivalents and restricted cash | |||||||||
-25,356 | 22,049 | 9,427 | - | - | - | - | - | - | - |
EFFECT OF EXCHANGE RATES ON CASH | |||||||||
- | - | - | -6 | -1 | -12 | -1 | 0 | -208 | -240 |
Decrease in cash and cash equivalents | |||||||||
- | - | - | 138,425 | -3,073 | 8,162 | -2,220 | 1,464 | -548 | 9,111 |
SUPPLEMENTAL CASH FLOW INFORMATION: | |||||||||
Cash paid for interest | |||||||||
- | 57 | 9 | - | - | - | - | - | - | - |
Cash paid for interest | |||||||||
- | - | - | 0 | 108 | 128 | 234 | 220 | 54 | 1,234 |
Cash paid for income taxes | |||||||||
- | - | - | - | - | - | - | - | 10 | 0 |
SUPPLEMENTAL NON-CASH FINANCING ACTIVITIES | |||||||||
Common Stock issued for acquired in-process research and development | |||||||||
3,791 | - | - | - | - | - | - | - | - | - |
Settlement of warrant liability for common stock | |||||||||
- | 3,345 | - | - | - | - | - | - | - | - |
Notes payable issued in conjunction with the exchange of warrants | |||||||||
- | 1,500 | - | - | - | - | - | - | - | - |
Conversion of convertible notes into common stock | |||||||||
- | - | 3,645 | - | - | - | - | - | - | - |
Accrued expenses and notes payable replaced with convertible notes | |||||||||
- | - | 1,077 | - | - | - | - | - | - | - |
Common stock warrant issued with convertible notes, net of issuance costs | |||||||||
- | - | 548 | - | - | - | - | - | - | - |
Addition of property and equipment not yet paid | |||||||||
- | - | 328 | - | - | - | - | - | - | - |
Billed lease incentive obligations not yet paid | |||||||||
- | - | 350 | - | - | - | - | - | - | - |
Value of warrants issued to lender in connection with loan | |||||||||
- | - | - | - | - | - | - | 69 | 0 | 0 |
Value of warrants issued in connection with issuance of common stock | |||||||||
- | - | - | - | - | - | - | - | 668 | 2,070 |
Series B Redeemable Convertible Preferred Stock [Member] | |||||||||
Proceeds from issuance of Series B redeemable convertible preferred stock and warrants, net of issuance costs | |||||||||
- | - | 13,018 | - | - | - | - | - | - | - |
Conversion of Series B redeemable convertible preferred stock into common stock | |||||||||
- | 9,790 | 3,479 | - | - | - | - | - | - | - |
Accretion of Series B redeemable convertible preferred stock | |||||||||
- | 2,894 | 4,766 | - | - | - | - | - | - | - |
Series B Preferred Stock [Member] | |||||||||
Conversion of Series B redeemable convertible preferred stock into common stock | |||||||||
- | - | 5 | - | - | - | - | - | - | - |